eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hepatic encephalopathy |
| Symptom | C0023890|liver cirrhosis |
| Sentences | 26 |
| PubMedID- 23225825 | Previously studies have investigated the effect of propofol on sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis.11,18 these studies found that propofol sedation during upper gastrointestinal endoscopy did not cause acute deterioration of sub-clinical hepatic encephalopathy.11,18 however, in patients with liver cirrhosis, hepatic function reserve is quite limited, and a cirrhotic liver is less tolerant to hemodynamic changes and surgical stress.1 therefore, anesthetic agents should be titrated with caution in cirrhotic patients to minimize the adverse effects of drugs and to stabilize hemodymanics. |
| PubMedID- 25459346 | Minimal hepatic encephalopathy in patients with liver cirrhosis: magnetic resonance spectroscopic brain findings versus neuropsychological changes. |
| PubMedID- 25100119 | Conclusion: probiotics decrease overt hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 25420740 | However, it is often very difficult to differentiate between cryptococcal meningitis and hepatic encephalopathy in patients with liver cirrhosis, and there is delay in making the diagnosis. |
| PubMedID- 25932262 | Aim: to determine the effects of small-intestinal bacterial overgrowth (sibo) and rifaximin therapy on minimal hepatic encephalopathy (mhe) with liver cirrhosis. |
| PubMedID- 25060166 | Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted mr imaging and proton mr spectroscopy of the brain. |
| PubMedID- 25867912 | Objective: to determine the efficacy of rifaximin once a day dose in the prevention of hepatic encephalopathy (he) in patients with liver cirrhosis as compared with twice daily dose of rifaximin. |
| PubMedID- 20852922 | The mean cff was higher in patients after liver transplantation, but did not reach statistical significance.table 2surrogate markers for hepatic encephalopathy in patients with liver cirrhosis and those who have received liver transplants. |
| PubMedID- 24709242 | Objective: to determine the efficacy of rifaximin in prevention of repeated episodes of hepatic encephalopathy in patients with liver cirrhosis as compared to placebo. |
| PubMedID- 25863779 | Patients with hepatic encephalopathy in liver cirrhosis and healthy controls ingested a 20-g solution of glutamine dissolved in 100 ml of tap water. |
| PubMedID- 24078984 | Oral glutamine challenge improves the performance of psychometric tests for the diagnosis of minimal hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 20642112 | Low doses are used as a food supplement and high doses (above 5 g) as a medicinal product to lower blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis. |
| PubMedID- 22791641 | Cognitive evoked response potentials in patients with liver cirrhosis without diagnosis of minimal or overt hepatic encephalopathy. |
| PubMedID- 22384773 | Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis. |
| PubMedID- 20934771 | Conclusions: sedation with propofol has a shorter time recovery and a shorter time to discharge than midazolam and does not exacerbate sub-clinical hepatic encephalopathy in patients with compensated liver cirrhosis. |
| PubMedID- 20482828 | Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin ii receptor blocker combination therapy: a case report. |
| PubMedID- 21757988 | He had been hospitalized several times for alcoholic liver cirrhosis with hepatic encephalopathy. |
| PubMedID- 20216550 | Increased blood-brain barrier (bbb) permeability for ammonia is considered to be an integral part of the pathophysiology of hepatic encephalopathy (he) in patients with liver cirrhosis. |
| PubMedID- 22870180 | Here we report on a patient suffered from liver cirrhosis with recurrent hepatic encephalopathy who developed mnz-induced neurotoxicity. |
| PubMedID- 26516441 | In our study, hyponatremia was associated with increased incidence of hepatic encephalopathy in patients with decompensated liver cirrhosis. |
| PubMedID- 25847088 | Aim: to examine whether the brain exhibits metabolic disorder prior to overt hepatic encephalopathy in patients with liver cirrhosis (lc), the intracerebral glutamine and myo-inositol levels were determined using 3.0-tesla (t)1 h (proton) magnetic resonance spectroscopy (mrs). |
| PubMedID- 21416318 | Pylori) bacteria convert urea to ammonia, which has been implicated in causation of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 25509200 | The role of fecal calprotectin in assessment of hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 20010298 | Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis. |
| PubMedID- 24974838 | Infection and liver cirrhosis: possible association with hepatic encephalopathy and/or post-hepatic encephalopathy cognitive impairment in patients with portal hypertension. |
| PubMedID- 21483460 | 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. |
Page: 1